Acciones Myovant Sciences Ltd.
Acciones
MYOV
BMG637AM1024
Biotecnología e investigación médica
Directores | Puesto | Edad | Desde |
---|---|---|---|
David C. Marek
CEO | Chief Executive Officer | 59 | 04/01/21 |
Adele Gulfo
BRD | Director/Board Member | 61 | 27/12/19 |
Marianne Romeo
PRN | Corporate Officer/Principal | 56 | - |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Adele Gulfo
BRD | Director/Board Member | 61 | 27/12/19 |
David C. Marek
CEO | Chief Executive Officer | 59 | 04/01/21 |
Director/Board Member | 59 | 22/10/22 |
Nombre | Peso | AuM | Varia. 1 de ene. | Calificación inversor |
---|---|---|---|---|
0.11% | 0 M€ | 0,00 % | - | |
0.08% | 0 M€ | 0,00 % | - |
Varia. 1 de ene. | Capi. | |
---|---|---|
-1,42 % | 41,52 mil M | |
+42,15 % | 39,9 mil M | |
+1,97 % | 38,83 mil M | |
-14,19 % | 26,05 mil M | |
+1,82 % | 23,78 mil M | |
-24,55 % | 18,26 mil M | |
-4,07 % | 11,65 mil M | |
+21,36 % | 11,53 mil M | |
+8,20 % | 11,2 mil M |